Answers are grounded in this paper and cite their sources.
Tumors avoid immune surveillance by inactivating various T-cell cytotoxic pathways that can promote cell death (1-3). Cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1) are expressed primarily on cytotoxic T lymphocytes. In contrast, programmed death ligand 1 (PD-L1) is expressed on antigen-presenting lymphoid and non-lymphoid tissues, on tumor cells, and on virus-infected cells.
No takes yet. Share an insight, caveat, or question.
Yanis Boumber (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: